These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 36991492)

  • 1. CRISPR screens identify gene targets at breast cancer risk loci.
    Tuano NK; Beesley J; Manning M; Shi W; Perlaza-Jimenez L; Malaver-Ortega LF; Paynter JM; Black D; Civitarese A; McCue K; Hatzipantelis A; Hillman K; Kaufmann S; Sivakumaran H; Polo JM; Reddel RR; Band V; French JD; Edwards SL; Powell DR; Chenevix-Trench G; Rosenbluh J
    Genome Biol; 2023 Mar; 24(1):59. PubMed ID: 36991492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of target genes and pathways at GWAS loci by pooled single-cell CRISPR screens.
    Morris JA; Caragine C; Daniloski Z; Domingo J; Barry T; Lu L; Davis K; Ziosi M; Glinos DA; Hao S; Mimitou EP; Smibert P; Roeder K; Katsevich E; Lappalainen T; Sanjana NE
    Science; 2023 May; 380(6646):eadh7699. PubMed ID: 37141313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of candidate causal variants and target genes at 41 breast cancer risk loci through differential allelic expression analysis.
    Xavier JM; Magno R; Russell R; de Almeida BP; Jacinta-Fernandes A; Besouro-Duarte A; Dunning M; Samarajiwa S; O'Reilly M; Maia AM; Rocha CL; Rosli N; Ponder BAJ; Maia AT
    Sci Rep; 2024 Sep; 14(1):22526. PubMed ID: 39341862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multimodal CRISPR perturbations of GWAS loci associated with coronary artery disease in vascular endothelial cells.
    Wünnemann F; Fotsing Tadjo T; Beaudoin M; Lalonde S; Lo KS; Kleinstiver BP; Lettre G
    PLoS Genet; 2023 Mar; 19(3):e1010680. PubMed ID: 36928188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel Thrombotic Function of a Human SNP in STXBP5 Revealed by CRISPR/Cas9 Gene Editing in Mice.
    Zhu QM; Ko KA; Ture S; Mastrangelo MA; Chen MH; Johnson AD; O'Donnell CJ; Morrell CN; Miano JM; Lowenstein CJ
    Arterioscler Thromb Vasc Biol; 2017 Feb; 37(2):264-270. PubMed ID: 28062498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CRISPR-Cas13d screens identify KILR, a breast cancer risk-associated lncRNA that regulates DNA replication and repair.
    Wang L; Bitar M; Lu X; Jacquelin S; Nair S; Sivakumaran H; Hillman KM; Kaufmann S; Ziegman R; Casciello F; Gowda H; Rosenbluh J; Edwards SL; French JD
    Mol Cancer; 2024 May; 23(1):101. PubMed ID: 38745269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computational Discovery of Cancer Immunotherapy Targets by Intercellular CRISPR Screens.
    Yim S; Hwang W; Han N; Lee D
    Front Immunol; 2022; 13():884561. PubMed ID: 35651625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mapping the functional impact of non-coding regulatory elements in primary T cells through single-cell CRISPR screens.
    Alda-Catalinas C; Ibarra-Soria X; Flouri C; Gordillo JE; Cousminer D; Hutchinson A; Sun B; Pembroke W; Ullrich S; Krejci A; Cortes A; Acevedo A; Malla S; Fishwick C; Drewes G; Rapiteanu R
    Genome Biol; 2024 Feb; 25(1):42. PubMed ID: 38308274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CRISPR Screens Provide a Comprehensive Assessment of Cancer Vulnerabilities but Generate False-Positive Hits for Highly Amplified Genomic Regions.
    Munoz DM; Cassiani PJ; Li L; Billy E; Korn JM; Jones MD; Golji J; Ruddy DA; Yu K; McAllister G; DeWeck A; Abramowski D; Wan J; Shirley MD; Neshat SY; Rakiec D; de Beaumont R; Weber O; Kauffmann A; McDonald ER; Keen N; Hofmann F; Sellers WR; Schmelzle T; Stegmeier F; Schlabach MR
    Cancer Discov; 2016 Aug; 6(8):900-13. PubMed ID: 27260157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of breast cancer associated variants that modulate transcription factor binding.
    Liu Y; Walavalkar NM; Dozmorov MG; Rich SS; Civelek M; Guertin MJ
    PLoS Genet; 2017 Sep; 13(9):e1006761. PubMed ID: 28957321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. H3K27ac HiChIP in prostate cell lines identifies risk genes for prostate cancer susceptibility.
    Giambartolomei C; Seo JH; Schwarz T; Freund MK; Johnson RD; Spisak S; Baca SC; Gusev A; Mancuso N; Pasaniuc B; Freedman ML
    Am J Hum Genet; 2021 Dec; 108(12):2284-2300. PubMed ID: 34822763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Multilayered Post-Genome-Wide Association Study Analysis Pipeline Defines Functional Variants and Target Genes for Systemic Lupus Erythematosus.
    Fazel-Najafabadi M; Looger LL; Rallabandi HR; Nath SK
    Arthritis Rheumatol; 2024 Jul; 76(7):1071-1084. PubMed ID: 38369936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple-gene targeting and mismatch tolerance can confound analysis of genome-wide pooled CRISPR screens.
    Fortin JP; Tan J; Gascoigne KE; Haverty PM; Forrest WF; Costa MR; Martin SE
    Genome Biol; 2019 Jan; 20(1):21. PubMed ID: 30683138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genome-wide CRISPR Screens in Primary Human T Cells Reveal Key Regulators of Immune Function.
    Shifrut E; Carnevale J; Tobin V; Roth TL; Woo JM; Bui CT; Li PJ; Diolaiti ME; Ashworth A; Marson A
    Cell; 2018 Dec; 175(7):1958-1971.e15. PubMed ID: 30449619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Translating non-coding genetic associations into a better understanding of immune-mediated disease.
    Stankey CT; Lee JC
    Dis Model Mech; 2023 Mar; 16(3):. PubMed ID: 36897113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A joint transcriptome-wide association study across multiple tissues identifies candidate breast cancer susceptibility genes.
    Gao G; Fiorica PN; McClellan J; Barbeira AN; Li JL; Olopade OI; Im HK; Huo D
    Am J Hum Genet; 2023 Jun; 110(6):950-962. PubMed ID: 37164006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of prostate cancer risk variants rs10993994 and rs7098889 by CRISPR/Cas9 mediated genome editing.
    Wang X; Hayes JE; Xu X; Gao X; Mehta D; Lilja HG; Klein RJ
    Gene; 2021 Feb; 768():145265. PubMed ID: 33122083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FORGEdb: a tool for identifying candidate functional variants and uncovering target genes and mechanisms for complex diseases.
    Breeze CE; Haugen E; Gutierrez-Arcelus M; Yao X; Teschendorff A; Beck S; Dunham I; Stamatoyannopoulos J; Franceschini N; Machiela MJ; Berndt SI
    Genome Biol; 2024 Jan; 25(1):3. PubMed ID: 38167104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CRISPR-mediated deletion of prostate cancer risk-associated CTCF loop anchors identifies repressive chromatin loops.
    Guo Y; Perez AA; Hazelett DJ; Coetzee GA; Rhie SK; Farnham PJ
    Genome Biol; 2018 Oct; 19(1):160. PubMed ID: 30296942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trans-ethnic follow-up of breast cancer GWAS hits using the preferential linkage disequilibrium approach.
    Zhu Q; Shepherd L; Lunetta KL; Yao S; Liu Q; Hu Q; Haddad SA; Sucheston-Campbell L; Bensen JT; Bandera EV; Rosenberg L; Liu S; Haiman CA; Olshan AF; Palmer JR; Ambrosone CB
    Oncotarget; 2016 Dec; 7(50):83160-83176. PubMed ID: 27825120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.